Skip to main content
Erschienen in: Journal of Bone and Mineral Metabolism 5/2023

11.07.2023 | Original Article

Untreated osteoporosis and higher FRAX as risk factors for tooth loss: a 5-year prospective study

verfasst von: Daniela Cia Penoni, Sandra Regina Torres, Matheus L. Oliveira, Maria Lucia Fleiuss Farias, Mario Vianna Vettore, Anna Thereza Thomé Leão

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Studies have shown that an impaired bone condition, represented by osteoporosis and increased fracture risk, may potentially aggravate periodontal disease and, consequently, the risk of tooth loss. This 5-year prospective study aimed to investigate whether systemic bone condition represents risk factor for tooth loss due to periodontal disease amongst elderly women.

Material and methods

Seventy-four participants, aged ≥ 65 years, who attended the 5-years recall for periodontal evaluation were involved. Baseline exposures were osteoporosis and fracture risk probabilities (FRAX). Women were grouped according to bone mineral density (BMD) and years of bone treatment for osteoporosis. The primary outcome at a 5-year follow-up was the number of tooth loss due to periodontal disease. Periodontitis staging and grading, and causes of tooth loss were recorded.

Results

The multivariate Poisson regression models showed that women with untreated/shortly treated osteoporosis were 4 times more likely to present higher number of tooth loss due to periodontal disease than those with normal BMD or treated for ≥ 3 years (risk ratio (RR) = 4.00, 95% CI 1.40–11.27). Higher FRAX was also linked to tooth loss (RR = 1.25, 95% CI 1.02–1.53). Receiver-operating characteristic (ROC) curve suggested that women with history of ≥ 1 tooth losses have higher chances of worse major FRAX (sensitivity = 72.2%; specificity = 72.2%).

Conclusion

In this 5-year study, higher FRAX and untreated osteoporosis were risk factors for tooth loss. Women with normal BMD or treated for osteoporosis for ≥ 3 years did not show increased risk. Management of skeletal conditions should be emphasized with periodontal care for the prevention of tooth loss in elderly women.
Literatur
1.
Zurück zum Zitat Friedman PK, Lamster IB (2016) Tooth loss as a predictor of shortened longevity: exploring the hypothesis. Periodontol 2000 72:142–152CrossRefPubMed Friedman PK, Lamster IB (2016) Tooth loss as a predictor of shortened longevity: exploring the hypothesis. Periodontol 2000 72:142–152CrossRefPubMed
2.
Zurück zum Zitat Penoni DC, Fidalgo TK, Torres SR, Varela VM, Masterson D et al (2017) Bone density and clinical periodontal attachment in postmenopausal women: a systematic review and meta-analysis. J Dent Res 96:261–269CrossRefPubMed Penoni DC, Fidalgo TK, Torres SR, Varela VM, Masterson D et al (2017) Bone density and clinical periodontal attachment in postmenopausal women: a systematic review and meta-analysis. J Dent Res 96:261–269CrossRefPubMed
3.
Zurück zum Zitat Jepsen S, Caton JG, Albandar JM, Bissada NF, Bouchard P et al (2018) Periodontal manifestations of systemic diseases and developmental and acquired conditions: consensus report of workgroup 3 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol 89:S237–S248CrossRefPubMed Jepsen S, Caton JG, Albandar JM, Bissada NF, Bouchard P et al (2018) Periodontal manifestations of systemic diseases and developmental and acquired conditions: consensus report of workgroup 3 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol 89:S237–S248CrossRefPubMed
4.
Zurück zum Zitat Albandar JM, Susin C, Hughes FJ (2018) Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: case definitions and diagnostic considerations. J Clin Periodontol 45:S171–S189CrossRefPubMed Albandar JM, Susin C, Hughes FJ (2018) Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: case definitions and diagnostic considerations. J Clin Periodontol 45:S171–S189CrossRefPubMed
5.
Zurück zum Zitat Almeida M, Laurent MR, Dubois V, Claessens F, O’Brien CA et al (2017) Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev 97:135–187CrossRefPubMed Almeida M, Laurent MR, Dubois V, Claessens F, O’Brien CA et al (2017) Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev 97:135–187CrossRefPubMed
6.
Zurück zum Zitat Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44CrossRefPubMed Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44CrossRefPubMed
7.
Zurück zum Zitat Curtis EM, Moon RJ, Harvey NC, Cooper C (2017) The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone 104:29–38CrossRefPubMedPubMedCentral Curtis EM, Moon RJ, Harvey NC, Cooper C (2017) The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. Bone 104:29–38CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Binkley N, Blank RD, Leslie WD, Lewiecki EM, Eisman JA, Bilezikian JP (2017) Osteoporosis in crisis: it’s time to focus on fracture. J Bone Miner Res 32:1391–1394CrossRefPubMed Binkley N, Blank RD, Leslie WD, Lewiecki EM, Eisman JA, Bilezikian JP (2017) Osteoporosis in crisis: it’s time to focus on fracture. J Bone Miner Res 32:1391–1394CrossRefPubMed
9.
Zurück zum Zitat Akram Z, Abduljabbar T, Kellesarian SV, Abu Hassan MI, Javed F, Vohra F (2017) Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review. Br J Clin Pharmacol 83:444–454CrossRefPubMed Akram Z, Abduljabbar T, Kellesarian SV, Abu Hassan MI, Javed F, Vohra F (2017) Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review. Br J Clin Pharmacol 83:444–454CrossRefPubMed
10.
Zurück zum Zitat Muniz F, Silva BFD, Goulart CR, Silveira TMD, Martins TM (2021) Effect of adjuvant bisphosphonates on treatment of periodontitis: systematic review with meta-analyses. J Oral Biol Craniofac Res 11:158–168CrossRefPubMedPubMedCentral Muniz F, Silva BFD, Goulart CR, Silveira TMD, Martins TM (2021) Effect of adjuvant bisphosphonates on treatment of periodontitis: systematic review with meta-analyses. J Oral Biol Craniofac Res 11:158–168CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Yu B, Wang CY (2022) Osteoporosis and periodontal diseases - an update on their association and mechanistic links. Periodontol 2000. 89:99–113CrossRefPubMed Yu B, Wang CY (2022) Osteoporosis and periodontal diseases - an update on their association and mechanistic links. Periodontol 2000. 89:99–113CrossRefPubMed
12.
Zurück zum Zitat Penoni DC, Torres SR, Farias ML, Fernandes TM, Luiz RR, Leao AT (2016) Association of osteoporosis and bone medication with the periodontal condition in elderly women. Osteoporos Int 27:1887–1896CrossRefPubMed Penoni DC, Torres SR, Farias ML, Fernandes TM, Luiz RR, Leao AT (2016) Association of osteoporosis and bone medication with the periodontal condition in elderly women. Osteoporos Int 27:1887–1896CrossRefPubMed
13.
Zurück zum Zitat Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the national osteoporosis guideline group and the international osteoporosis foundation. Arch Osteoporos 11:25CrossRefPubMedPubMedCentral Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV (2016) A systematic review of intervention thresholds based on FRAX: a report prepared for the national osteoporosis guideline group and the international osteoporosis foundation. Arch Osteoporos 11:25CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381CrossRefPubMedPubMedCentral Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359–2381CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Eke PI, Dye B (2009) Assessment of self-report measures for predicting population prevalence of periodontitis. J Periodontol 80:1371–1379CrossRefPubMed Eke PI, Dye B (2009) Assessment of self-report measures for predicting population prevalence of periodontitis. J Periodontol 80:1371–1379CrossRefPubMed
16.
Zurück zum Zitat Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ (2012) Update of the case definitions for population- based surveillance of periodontitis. J Periodontol 83:1449CrossRefPubMedPubMedCentral Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ (2012) Update of the case definitions for population- based surveillance of periodontitis. J Periodontol 83:1449CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Tonetti MS, Greenwell H, Kornman KS (2018) Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol 45:S149-s161CrossRefPubMed Tonetti MS, Greenwell H, Kornman KS (2018) Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol 45:S149-s161CrossRefPubMed
18.
Zurück zum Zitat Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M et al (2018) Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol 45:S162–S170CrossRefPubMed Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M et al (2018) Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol 45:S162–S170CrossRefPubMed
20.
Zurück zum Zitat Kalinowski P, Rozylo-Kalinowska I, Piskorz M, Bojakowska-Komsta U (2019) Correlations between periodontal disease, mandibular inferior cortex index and the osteoporotic fracture probability assessed by means of the fracture risk assessment body mass index tool. BMC Med Imaging 19:41CrossRefPubMedPubMedCentral Kalinowski P, Rozylo-Kalinowska I, Piskorz M, Bojakowska-Komsta U (2019) Correlations between periodontal disease, mandibular inferior cortex index and the osteoporotic fracture probability assessed by means of the fracture risk assessment body mass index tool. BMC Med Imaging 19:41CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Alli F, Bhandal GK, Thacker HL, Palomo L (2015) Can the FRAX tool be a useful aid for clinicians in referring women for periodontal care? Menopause J North Am Menopause Soc 22:75–78CrossRef Alli F, Bhandal GK, Thacker HL, Palomo L (2015) Can the FRAX tool be a useful aid for clinicians in referring women for periodontal care? Menopause J North Am Menopause Soc 22:75–78CrossRef
22.
Zurück zum Zitat LaMonte MJ, Hovey KM, Genco RJ, Millen AE, Trevisan M, Wactawski-Wende J (2013) Five-year changes in periodontal disease measures among postmenopausal females: the buffalo osteoperio study. J Periodontol 84:572–584CrossRefPubMed LaMonte MJ, Hovey KM, Genco RJ, Millen AE, Trevisan M, Wactawski-Wende J (2013) Five-year changes in periodontal disease measures among postmenopausal females: the buffalo osteoperio study. J Periodontol 84:572–584CrossRefPubMed
23.
Zurück zum Zitat Needleman I, Garcia R, Gkranias N, Kirkwood KL, Kocher T et al (2018) Mean annual attachment, bone level, and tooth loss: a systematic review. J Clin Periodontol 45:S112–S129CrossRefPubMed Needleman I, Garcia R, Gkranias N, Kirkwood KL, Kocher T et al (2018) Mean annual attachment, bone level, and tooth loss: a systematic review. J Clin Periodontol 45:S112–S129CrossRefPubMed
24.
Zurück zum Zitat Shah NP, Nayee S, Pazianas M, Sproat C (2017) Beyond ONJ - a review of the potential uses of bisphosphonates in dentistry. Br Dent J 222:727–730CrossRefPubMed Shah NP, Nayee S, Pazianas M, Sproat C (2017) Beyond ONJ - a review of the potential uses of bisphosphonates in dentistry. Br Dent J 222:727–730CrossRefPubMed
25.
Zurück zum Zitat Sedghizadeh PP, Sun S, Jones AC, Sodagar E, Cherian P et al (2021) Bisphosphonates in dentistry: historical perspectives, adverse effects, and novel applications. Bone 147:115933CrossRefPubMedPubMedCentral Sedghizadeh PP, Sun S, Jones AC, Sodagar E, Cherian P et al (2021) Bisphosphonates in dentistry: historical perspectives, adverse effects, and novel applications. Bone 147:115933CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Madeira M, Rocha AC, Moreira CA, Aguiar ÁMM, Maeda SS et al (2020) Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis - a position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso). Arch Endocrinol Metab. https://doi.org/10.20945/2359-3997000000301 Madeira M, Rocha AC, Moreira CA, Aguiar ÁMM, Maeda SS et al (2020) Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis - a position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso). Arch Endocrinol Metab. https://​doi.​org/​10.​20945/​2359-3997000000301
27.
Zurück zum Zitat Kim SH, Lee YK, Kim TY, Ha YC, Jang S, Kim HY (2021) Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: a nationwide cohort-study. Bone 143:115650CrossRefPubMed Kim SH, Lee YK, Kim TY, Ha YC, Jang S, Kim HY (2021) Incidence of and risk for osteonecrosis of the jaw in Korean osteoporosis patients treated with bisphosphonates: a nationwide cohort-study. Bone 143:115650CrossRefPubMed
28.
Zurück zum Zitat Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American association of oral and maxillofacial surgeons’ position paper on medication-related osteonecrosis of the Jaws-2022 update. J Oral Maxillofac Surg 80:920–943CrossRefPubMed Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American association of oral and maxillofacial surgeons’ position paper on medication-related osteonecrosis of the Jaws-2022 update. J Oral Maxillofac Surg 80:920–943CrossRefPubMed
29.
Zurück zum Zitat Briggs AM, Shiffman J, Shawar YR, Åkesson K, Ali N, Woolf AD (2020) Global health policy in the 21st century: challenges and opportunities to arrest the global disability burden from musculoskeletal health conditions. Best Pract Res Clin Rheumatol 34:101549CrossRefPubMedPubMedCentral Briggs AM, Shiffman J, Shawar YR, Åkesson K, Ali N, Woolf AD (2020) Global health policy in the 21st century: challenges and opportunities to arrest the global disability burden from musculoskeletal health conditions. Best Pract Res Clin Rheumatol 34:101549CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1789–1858 CrossRef GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1789–1858 CrossRef
31.
Zurück zum Zitat Compston J, Cooper A, Cooper C, Gittoes N, Gregson C et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12:43CrossRefPubMedPubMedCentral Compston J, Cooper A, Cooper C, Gittoes N, Gregson C et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12:43CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S et al (2020) Treatment of stage I-III periodontitis-the EFP S3 level clinical practice guideline. J Clin Periodontol. 47:4–60CrossRefPubMedPubMedCentral Sanz M, Herrera D, Kebschull M, Chapple I, Jepsen S et al (2020) Treatment of stage I-III periodontitis-the EFP S3 level clinical practice guideline. J Clin Periodontol. 47:4–60CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Cota LOM, Villar CC, Vettore MV, Campos JR, Amaral G et al (2021) Periodontal diseases: is it possible to prevent them? A populational and individual approach. Braz Oral Res 35:e098CrossRefPubMed Cota LOM, Villar CC, Vettore MV, Campos JR, Amaral G et al (2021) Periodontal diseases: is it possible to prevent them? A populational and individual approach. Braz Oral Res 35:e098CrossRefPubMed
Metadaten
Titel
Untreated osteoporosis and higher FRAX as risk factors for tooth loss: a 5-year prospective study
verfasst von
Daniela Cia Penoni
Sandra Regina Torres
Matheus L. Oliveira
Maria Lucia Fleiuss Farias
Mario Vianna Vettore
Anna Thereza Thomé Leão
Publikationsdatum
11.07.2023
Verlag
Springer Nature Singapore
Erschienen in
Journal of Bone and Mineral Metabolism / Ausgabe 5/2023
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-023-01451-w

Weitere Artikel der Ausgabe 5/2023

Journal of Bone and Mineral Metabolism 5/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.